Health
Synthetic Mini-Antibody Binds to and Neutralizes SARS-CoV-2 – Technology Networks
Extremely small antibodies, known as nanobodies, have been shown to neutralize SARS-CoV-2. But they’re extracted from llamas and camels, which is problematic for…
Llamas, camels and COVID-19
For SARS-CoV-2 to infect humans, the viral Spike (S) protein must interact with and bind to the angiotensin-converting enzyme 2 (ACE2) receptor on the surface of human cells. The S protein achieves this via the receptor binding domains (RBDs), and thus blocking the RBD using antibodies is just one therapeutic avenue that is being explored for the treatment of SARS-CoV-2. Back in May, Technology Networks covered the work of scientists exploring the potential utility of…
-
Noosa News24 hours agoDog daycare program a TikTok hit for helping disabled find work, friends
-
Noosa News24 hours agoAdvocates highlight sexual violence against older people, with Queensland elder abuse inquiry underway
-
Business22 hours ago3 steps to take to build a $1,000 monthly passive income
-
Business24 hours ago3 unstoppable ASX ETFs to buy and hold for 10 years